Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1235 of 6351
-
Promising drug combo targets aggressive brain cancers in youth
Disease control Not yet recruitingThe goal of this study is to further evaluate feasibility and tolerability of Opdualag for patients with replication repair deficient HGG, including DIPG.
Phase 2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Sep 10, 2026 02:00 UTC
-
Could a lower dose of blood cancer drugs be just as effective?
Disease control Not yet recruitingBLOOD-dose is a multicentre, adaptive, randomized, multidomain platform trial designed to optimize treatment dosing strategies in adult patients with haematological diseases. The BLOOD-dose core protocol outlines the overall clinical trial design that applies to all included int…
Phase 4 • Sponsor: Anne Louise Tølbøll Sørensen • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Can a new pill tame inflammatory bowel disease?
Disease control Not yet recruitingThis is a double-blind, randomized, placebo-controlled study, consisting of a single ascending dose (SAD) part with integrated food effect (FE) arm, and a multiple ascending dose (MAD) part to assess the safety, tolerability, and PK of ascending single and multiple oral doses of …
Phase 1 • Sponsor: Lmito Therapeutics Inc. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
A smartphone app may lighten the load for hispanic dementia caregivers
Symptom relief Not yet recruitingThe goal of this clinical trial is to evaluate usability, feasibility and preliminary efficacy of a mobile telehealth supported behavioral intervention for caregivers of persons with dementia who identify as Hispanic. The main question it aims to answer is: "is a mobile telehealt…
Sponsor: Indiana University • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
New hope for brain tumor patients when standard drug fails
Disease control Not yet recruitingThis study will include up to 40 participants with Grade 2 or Grade 3 IDH1-mutant glioma who have undergone surgery and received vorasidenib as their only treatment, experienced radiographic disease progression on vorasidenib (confirmed by Blinded Independent Central Review \[BIC…
Phase 2 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New heart valve clip shows promise in early trial
Disease control Not yet recruitingShenzhen Lifevalve Medical Scientific Co., Ltd. has developed a new X-Clip Mitral Valve Clip System and its compatible Steerable Guide System, aiming to provide transcatheter mitral valve repair for patients with degenerative mitral regurgitation. The two systems have completed a…
Sponsor: Shenzhen Lifevalve Medical Scientific Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Aspirin may fight Cancer-Causing inflammation in the womb
Prevention Not yet recruitingThis phase IV trial studies whether low dose aspirin can be used to lower inflammation and prevent endometrial cancer in postmenopausal women with changes in the endometrial tissue that are not related to thinning (non-atrophic endometrial changes) and pain. As people age, there …
Phase 4 • Sponsor: Mayo Clinic • Aim: Prevention
Last updated Aug 07, 2026 00:00 UTC
-
New hope for kids with ITP: drug combo aims to control bleeding
Disease control Not yet recruitingThe purpose of this study is to assess the efficacy, safety and pharmacokinetics (PK) of ianalumab (VAY736) in addition to eltrombopag treatment; and to inform the dose of ianalumab in pediatric patients (5 to \<18 years of age) with primary ITP who have had an insufficient respo…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New sciatica shot could offer lasting pain relief
Symptom relief Not yet recruitingThis is a research study of SP-102, an experimental medication designed to relieve pain in patients with moderate to severe sciatica (pain in the lower back, hips, buttocks and legs). SP-102, placebo (a medication that looks like SP-102 but does not contain any active ingredient)…
Phase 3 • Sponsor: Semnur Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Sep 10, 2026 02:00 UTC
-
Nurse-Led mobile clinics aim to tame high blood pressure in liberia
Disease control Not yet recruitingThe goal of this study is to learn if a nurse-led, task-shifting, community-based program can help lower blood pressure in adults aged 25 and older with uncontrolled high blood pressure (hypertension) in Monrovia, Liberia. The program is delivered through community-based mobile c…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could your own fat cells protect your new liver?
Disease control Not yet recruitingThe purpose of this study is to assess the safety of autologous Adipose-Derived Mesenchymal Stem Cell for use in End-Stage Liver Disease patients undergoing the creation of a duct-to-duct anastomosis during Living Donor Liver Transplantation.
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could social media posts curb the tanning habit?
Prevention Not yet recruitingThe goal of this randomized controlled trial is to test the efficacy of a dissonance induction intervention compared to a control group on tanning in 278 young adult tanners. The primary outcome will be tanning at 3-months. Secondary outcomes include tanning at 15-months and sunb…
Sponsor: University of Connecticut • Aim: Prevention
Last updated Aug 09, 2026 00:00 UTC
-
Virtual therapy may ease breast cancer treatment side effects
Symptom relief Not yet recruitingThe goal of this study is to demonstrate the efficacy of an evidence-based, small-group, telehealth intervention ('STRIDE') for improving patients' ability to cope with side effects from adjuvant endocrine therapy (AET) and adhere to AET medication regimens for patients with horm…
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Vitamin e may shield the thyroid: a new trial tests the Antioxidant's power
Disease control By invitation onlyThe aim of this study is to learn if vitamin E supplementation as an adjunct to levothyroxine therapy help to reduce oxidative stress, improve antioxidant defence mechanisms, and favourably influence thyroid hormone status, making it a promising therapeutic strategy for patients …
Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can yearly heart scans catch rheumatic disease early in children?
Knowledge-focused Not yet recruitingThis study will look at how many children develop rheumatic heart disease (RHD) over a 3-year period. The study will include children ages 5 to 8 who do not have RHD at the start and who live in areas where the disease is common. Each child will have a heart ultrasound (echocardi…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
New program aims to curb suicide risk in teens on probation
Knowledge-focused Recruiting nowThe goal of this study is to conduct a pilot test of a mental health support program called the Youth-Nominated Support Team - Probation (YST-P) for young people ages 12-17 on probation, experiencing suicidal ideation and behaviors (SIB). Young people on probation experience SIB …
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
New pill could regrow hair in balding men
Disease control Not yet recruitingThis study is a Phase 3 clinical trial designed to evaluate the efficacy and safety of N1087 compared with placebo in adult men with androgenetic alopecia (male pattern hair loss). The study will include male participants aged 18 to 60 years who have a clinical diagnosis of andr…
Phase 3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Virtual nature walks may ease pain and fear during needle procedures
Symptom relief Not yet recruitingMedical and technological advancements allow increasingly complex invasive procedures to be performed on hospitalized patients, improving their survival rates and prognosis. However, these interventions impact physical, emotional, and psychological health. In this scenario, post-…
Sponsor: diana garcia • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Can a chatbot and peer groups help youth with HIV stay healthy?
Disease control Not yet recruitingYouth living with HIV (YLWH) experience mental health (MH) challenges that compromise their HIV care. Though the MH gap is well described, MH service delivery to YLWH is rare, especially in low resource settings. MH professionals are few and interventions tailored to the needs of…
Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can exposing food industry tricks curb junk food cravings?
Knowledge-focused Not yet recruitingThe primary objective of this study is to identify the food counter-marketing messages (i.e., messages that describe deceptive marketing tactics used by food companies) that are perceived as most effective among young adults.
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC